Literature DB >> 5546649

Autoradiographic demonstration of uptake and accumulation of 3H-6-hydroxydopamine in adrenergic nerves.

A Ljungdahl, T Hökfelt, G Jonsson, C Sachs.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1971        PMID： 5546649     DOI： 10.1007/bf02138157

Source DB:  PubMed          Journal:  Experientia        ISSN： 0014-4754


× No keyword cloud information.
  16 in total

1.  COMPARISON OF SOME PHARMACOLOGIC EFFECTS OF CERTAIN 6-SUBSTITUTED DOPAMINE DERIVATIVES WITH RESERPINE, GUANETHIDINE AND METARAMINOL.

Authors:  C A STONE; J M STAVORSKI; C T LUDDEN; H C WENGER; C A ROSS; J A TOTARO; C C PORTER
Journal:  J Pharmacol Exp Ther       Date:  1963-11       Impact factor: 4.030

2.  ACTION OF 2, 4, 5-TRIHYDROXYPHENYLETHYLAMINE ON THE STORAGE AND RELEASE OF NORADRENALINE.

Authors:  R LAVERTY; D F SHARMAN; M VOGT
Journal:  Br J Pharmacol Chemother       Date:  1965-04

3.  Effect of 6-hydroxydopamine and some other compounds on the concentration of norepinephrine in the hearts of mice.

Authors:  C C PORTER; J A TOTARO; C A STONE
Journal:  J Pharmacol Exp Ther       Date:  1963-06       Impact factor: 4.030

4.  [Electron microscopy studies on the peripheral sympathetic nervous system of the cat; physiological and pharmacological aspects].

Authors:  J P Tranzer; H Thoenen
Journal:  Naunyn Schmiedebergs Arch Exp Pathol Pharmakol       Date:  1967

5.  Chemical sympathectomy of the cat with 6-hydroxydopamine.

Authors:  G Haeusler; W Haefely; H Thoenen
Journal:  J Pharmacol Exp Ther       Date:  1969-11       Impact factor: 4.030

6.  6-Hydroxy-dopamine induced degeneration of central monoamine neurons.

Authors:  U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1968-12       Impact factor: 4.432

7.  Effects of 6-hydroxydopamine on noradrenaline-containing neurones in the rat brain.

Authors:  N J Uretsky; L L Iversen
Journal:  Nature       Date:  1969-02-08       Impact factor: 49.962

8.  The relationship between radioactivity and norepinephrine concentrations in the brains and hearts of mice following administration of labeled methyldopa or 6-hydroxydopamine.

Authors:  C C Porter; J A Totaro; A Burcin
Journal:  J Pharmacol Exp Ther       Date:  1965-10       Impact factor: 4.030

9.  A modification of dry-mounting technique for radioautography of water-soluble compounds.

Authors:  T Nagata; T Nawa
Journal:  Histochemie       Date:  1966

10.  An ultrastructural and histochemical study of the short-term effects of 6-hydroxydopamine on adrenergic nerves in the domestic fowl.

Authors:  T Bennett; G Burnstock; J L Cobb; T Malmfors
Journal:  Br J Pharmacol       Date:  1970-04       Impact factor: 8.739
View more
  10 in total

1.  RA Differentiation Enhances Dopaminergic Features, Changes Redox Parameters, and Increases Dopamine Transporter Dependency in 6-Hydroxydopamine-Induced Neurotoxicity in SH-SY5Y Cells.

Authors:  Fernanda M Lopes; Leonardo Lisbôa da Motta; Marco A De Bastiani; Bianca Pfaffenseller; Bianca W Aguiar; Luiz F de Souza; Geancarlo Zanatta; Daiani M Vargas; Patrícia Schönhofen; Giovana F Londero; Liana M de Medeiros; Valder N Freire; Alcir L Dafre; Mauro A A Castro; Richard B Parsons; Fabio Klamt
Journal:  Neurotox Res       Date:  2017-02-02       Impact factor: 3.911

2.  Selective uptake of 3H-6-hydroxydopamine by neurones of the central nervous system.

Authors:  P Schubert; G W Kreutzberg; K Reinhold; A Herz
Journal:  Exp Brain Res       Date:  1973-07-30       Impact factor: 1.972

Review 3.  Chromaffin cells as a model to evaluate mechanisms of cell death and neuroprotective compounds.

Authors:  Cristobal de Los Rios; Maria F Cano-Abad; Mercedes Villarroya; Manuela G López
Journal:  Pflugers Arch       Date:  2017-08-19       Impact factor: 3.657

4.  Protective effect of hydrogen sulphide against 6-OHDA-induced cell injury in SH-SY5Y cells involves PKC/PI3K/Akt pathway.

Authors:  Chi Xin Tiong; Ming Lu; Jin-Song Bian
Journal:  Br J Pharmacol       Date:  2010-09       Impact factor: 8.739

5.  Variability among brain regions in the specificity of 6-hydroxydopamine (6-OHDA)-induced lesions.

Authors:  D L Commins; R A Shaughnessy; K J Axt; G Vosmer; L S Seiden
Journal:  J Neural Transm       Date:  1989       Impact factor: 3.575

6.  The localization of acetylcholinesterase in the locus coeruleus of the normal rat and after 6-hydroxydopamine treatment.

Authors:  P R Lewis; F E Schon
Journal:  J Anat       Date:  1975-11       Impact factor: 2.610

7.  Degenerative processes after punctate intracerebral administration of 6-hydroxydopamine.

Authors:  L L Butcher
Journal:  J Neural Transm       Date:  1975       Impact factor: 3.575

8.  Extraneuronal effects of 6-hydroxydopamine and extraneuronal uptake of noradrenaline. In-vivo and in-vitro studies on adrenocortical cells of lizards and rats.

Authors:  K Unsicker; I J Allan; D F Newgreen
Journal:  Cell Tissue Res       Date:  1976-10-01       Impact factor: 5.249

9.  Agmatine Protects Against 6-OHDA-Induced Apoptosis, and ERK and Akt/GSK Disruption in SH-SY5Y Cells.

Authors:  Esmat Amiri; Rasoul Ghasemi; Maryam Moosavi
Journal:  Cell Mol Neurobiol       Date:  2015-09-07       Impact factor: 5.046

10.  The neuroprotective effect of BSA-based nanocurcumin against 6-OHDA-induced cell death in SH-SY5Y cells.

Authors:  Roksana Sookhaklari; Bita Geramizadeh; Morteza Abkar; Maryam Moosavi
Journal:  Avicenna J Phytomed       Date:  2019 Mar-Apr
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.